Question 1

How many shares of SLNO does Carlyle Group Inc. own?

Accepted Answer

Carlyle Group Inc. previously held 0 shares of SLNO (SOLENO THERAPEUTICS INC) before exiting the position in 2025-Q3.

Question 2

What is Carlyle Group Inc.'s SLNO position worth?

Accepted Answer

Carlyle Group Inc.'s SLNO position was last reported at $0 in 2025-Q3 before the exit.

Question 3

Is Carlyle Group Inc. buying or selling SLNO?

Accepted Answer

In 2025-Q3, Carlyle Group Inc. exited their SLNO position entirely (-100.0% change in shares).

Question 4

When did Carlyle Group Inc. first buy SLNO?

Accepted Answer

Based on available 13F filings, Carlyle Group Inc. first reported a position in SLNO in 2023-Q1. They have held the position across 11 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$68.16	0
2025-Q2	Unchanged	860,980	0.0%	$72.1M	1.4%	$83.25	0
2025-Q1	Decreased	860,980	-37.4%	$61.4M	1.6%	$71.99	0
2024-Q4	Decreased	1.4M	-66.2%	$61.8M	1.5%	$45.30	0
2024-Q3	Unchanged	4.1M	0.0%	$205.4M	21.5%	$49.13	0
2024-Q2	Unchanged	4.1M	0.0%	$166.4M	15.8%	$40.80	0
2024-Q1	Increased	4.1M	+42.5%	$173.1M	10.9%	$42.80	80
2023-Q4	Increased	2.9M	+24.6%	$115M	5.5%	$40.25	72
2023-Q3	Increased	2.3M	+90.9%	$67.4M	2.9%	$29.51	81
2023-Q2	Unchanged	1.2M	0.0%	$5.1M	0.2%	$4.20	0
2023-Q1	New	1.2M	-	$2.5M	0.1%	$2.21	37

SLNO11 quarters

SLNO
11 quarters